Earnings Feed
Start Free
Home/Filings/4/0001256928-09-000023
4//SEC Filing

ARONSON SHEREE L 4

Accession 0001256928-09-000023

CIK 0001168335other
View on SEC.govCompany Profile

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 8:52 PM ET

Size

40.1 KB

Accession

0001256928-09-000023

Insider Transaction Report

Form 4
Period: 2009-02-25
ABBOTT MEDICAL OPTICS INCEYE
ARONSON SHEREE L
Corporate Vice President
Transactions
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−771$16,962→ 0 total
  • Award

    Common Stock

    2009-02-25+1,000→ 1,000 total
  • Tax Payment

    Common Stock

    2009-02-25$22.01/sh−358$7,880→ 642 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−642$14,124→ 0 total
  • Award

    Common Stock

    2009-02-25+1,400→ 1,400 total
  • Tax Payment

    Common Stock

    2009-02-25$22.01/sh−501$11,027→ 899 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−899$19,778→ 0 total
  • Award

    Common Stock

    2009-02-25+1,780→ 1,780 total
  • Disposition from Tender

    Common Stock

    2009-02-25$22.00/sh−1,806.183$39,736→ 1,116.086 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−116.086$2,554→ 1,000 total
  • Tax Payment

    Common Stock

    2009-02-25$22.01/sh−358$7,880→ 642 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−642$14,124→ 0 total
  • Award

    Common Stock

    2009-02-25+1,200→ 1,200 total
  • Tax Payment

    Common Stock

    2009-02-25$22.01/sh−429$9,442→ 771 total
  • Tax Payment

    Common Stock

    2009-02-25$22.01/sh−637$14,020→ 1,143 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−1,143$25,146→ 0 total
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2009-02-26−25,000→ 0 total
    Exercise: $33.72From: 2008-05-20Exp: 2018-05-20→ Common Stock (25,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2009-02-26−20,000→ 0 total
    Exercise: $38.20From: 2009-02-25Exp: 2015-05-26→ Common Stock (20,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2009-02-26−11,000→ 0 total
    Exercise: $42.55From: 2009-02-25Exp: 2017-05-21→ Common Stock (11,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2009-02-26−17,980→ 0 total
    Exercise: $22.94From: 2009-02-25Exp: 2018-05-29→ Common Stock (17,980 underlying)
Footnotes (9)
  • [F1]These shares were tendered to Rainforest Acquisition Inc. ("Purchaser") pursuant to Purchaser?s offer to purchase all of the outstanding shares of Advanced Medical Optics, Inc. (the "Issuer") at a cash purchase price of $22.00 per share, without interest, and subject to any required withholding taxes, subject to the terms described in the Offer to Purchase, filed with the SEC on January 27, 2009, as amended (the "Tender Offer"). Such shares were purchased by Purchaser pursuant to the Tender Offer on February 25, 2009.
  • [F2]Includes an aggregate of 1,922.2686 shares of common stock acquired through the issuer's Employee Stock Purchase Plan through February 24, 2009.
  • [F3]These shares were canceled pursuant to the Agreement and Plan of Merger, dated January 11, 2009, by and among Abbott Laboratories, Purchaser and the Issuer (the "Merger Agreement"), in exchange for the right to receive cash payment of $22.00 per share in cash (without interest and subject to any required withholding taxes) at the effective time of the merger.
  • [F4]Shares withheld in satisfaction of tax obligations attributable to the lapse of restrictions on stock award or in satisfaction of tax withholding attributable to vesting and settlement of restricted stock units.
  • [F5]The exempt restricted stock units (previously reported on Table II) vested in full and were settled for shares of Issuer Common Stock in accordance with the terms of the applicable equity plan. At the effective time of the merger, such shares were cancelled pursuant to the Merger Agreement in exchange for the right to receive cash payment of $22.00 per share in cash (without interest and subject to any required withholding taxes).
  • [F6]This previously reported exempt stock option, which had vested as to 100% of the underlying shares in accordance with its terms, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 10,257 shares of Abbott Laboratories common stock at an exercise price of $82.19 per share, determined pursuant to a formula set forth in the Merger Agreement.
  • [F7]This previously reported exempt stock option, which had vested as to 100% of the underlying shares in accordance with its terms, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 8,205 shares of Abbott Laboratories common stock at an exercise price of $93.11 per share, determined pursuant to a formula set forth in the Merger Agreement.
  • [F8]This previously reported exempt stock option, which was to have vested ratably over the first four years from the date of grant, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 4,513 shares of Abbott Laboratories common stock at an exercise price of $103.71 per share, determined pursuant to a formula set forth in the Merger Agreement.
  • [F9]This previously reported exempt stock option, which was to have vested ratably over the first four years from the date of grant, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 7,377 shares of Abbott Laboratories common stock at an exercise price of $55.92 per share, determined pursuant to a formula set forth in the Merger Agreement.

Documents

1 file

Issuer

ABBOTT MEDICAL OPTICS INC

CIK 0001168335

→
Entity typeother

Related Parties

1
  • filerCIK 0001256927

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 8:52 PM ET
Size
40.1 KB
View on SEC.gov